Vfend Special Investigation For Pediatric - Observational

Pfizer

Status: Completed

Conditions: Pediatric Safety and Effectiveness

Study type: Observational

Funder types: Industry

Identifiers

NCT02554656

A1501100

Details and patient eligibility

About

Examine the safety and effectiveness of Vfend [voriconazole] for pediatric under general clinical practices.

Enrollment: 89 patients

Sex: All

Ages: Under 15 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who is under 15 years old and deep mycosis infection.

Exclusion criteria

• Patients who have been previously enrolled in this study. -

Trial design